https://auntresodamid.com/iJugHxINePLH1VY/96561

Business News

Target names longtime insider Michael Fiddelke its next CEO as retailer tries to break sales and stock slump

Target names longtime insider Michael Fiddelke its next CEO as retailer tries to break sales and stock slump

Target’s Chief Operating Officer Michael Fiddelke will take over as CEO from Brian Cornell. Courtesy of Target Target on Wednesday said that company veteran Michael Fiddelke will become its next CEO at a critical point in its effort to break out of a sales slump and win back Wall Street’s favor. Fiddelke, the company’s 49-year-old […]

Target names longtime insider Michael Fiddelke its next CEO as retailer tries to break sales and stock slump Read More »

Alaska Airlines launches 5 credit card in premium travel race, combines loyalty program with Hawaiian

Alaska Airlines launches $395 credit card in premium travel race, combines loyalty program with Hawaiian

An Alaska Airlines Boeing 737 MAX 9 departs Los Angeles International Airport en route to Puerto Vallarta on Sept. 19, 2024. Kevin Carter | Getty Images Alaska Airlines is getting into the industry’s race for high-end credit cards and creating a combined frequent flyer program, called Atmos Rewards, with Hawaiian Airlines, which it acquired last

Alaska Airlines launches $395 credit card in premium travel race, combines loyalty program with Hawaiian Read More »

Lowe’s beats on quarterly earnings, buys home pros business for .8 billion

Lowe’s beats on quarterly earnings, buys home pros business for $8.8 billion

An exterior view of a Lowe’s home improvement store in Selinsgrove. Paul Weaver | Lightrocket | Getty Images Lowe’s beat Wall Street’s earning expectations on Wednesday as demand for home projects picked up during the quarter. The retailer also announced its latest effort to attract more business from home professionals. It said on Wednesday that

Lowe’s beats on quarterly earnings, buys home pros business for $8.8 billion Read More »

FDA approves first-ever glucose monitoring system for weight loss from Signos 

FDA approves first-ever glucose monitoring system for weight loss from Signos 

Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight.  Current treatment options for losing weight – popular drugs like GLP-1s and surgical interventions – are

FDA approves first-ever glucose monitoring system for weight loss from Signos  Read More »

From sweet treats to protein boosts, chains are banking on beverages to drive sales

From sweet treats to protein boosts, chains are banking on beverages to drive sales

If it feels like there are a lot of new drinks on restaurant menus, it’s because there are. Driven by younger consumers who crave customized, cold beverages, chains from Dunkin’ to Dutch Bros, Starbucks and McDonald’s are answering the call. The number of beverages offered by the top 500 chains has increased by more than

From sweet treats to protein boosts, chains are banking on beverages to drive sales Read More »

‘Stranger Things’ creators, the Duffer Brothers, ink 4-year deal with Paramount Skydance

‘Stranger Things’ creators, the Duffer Brothers, ink 4-year deal with Paramount Skydance

Matt Duffer and Ross Duffer attend “Stranger Things” and Award Presentation To The Duffer Brothers (Variety Showrunner Award) during Day 1 of the 13th SCAD TVfest on February 05, 2025 in Atlanta, Georgia. Paras Griffin | Getty Images Entertainment | Getty Images The masterminds behind the hit Netflix series “Stranger Things” have inked a new

‘Stranger Things’ creators, the Duffer Brothers, ink 4-year deal with Paramount Skydance Read More »

Viking Therapeutics shares fall 40% on disappointing obesity pill trial data

Viking Therapeutics shares fall 40% on disappointing obesity pill trial data

Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors.  The results could be a blow to Viking, which was once seen as a hot M&A target as pharmaceutical companies scramble to join the booming market for obesity and diabetes drugs. It could

Viking Therapeutics shares fall 40% on disappointing obesity pill trial data Read More »

Don’t miss latest news!

Select list(s):

We don’t spam! Read our [link]privacy policy[/link] for more info.

🕶 Relax!

Put your feet up and let us do the hard work for you. Sign up to receive our latest news directly in your inbox.

Select Your Choice:

We’ll never send you spam or share your email address.
Find out more in our Privacy Policy.

Scroll to Top